Literature DB >> 22117896

Identification of target genes for the CDK subunits of the Mediator complex.

Taiki Tsutsui1, Rikiya Fukasawa, Aki Tanaka, Yutaka Hirose, Yoshiaki Ohkuma.   

Abstract

Mediator is a large complex containing up to 30 subunits that consist of four modules each: head, middle, tail and CDK/Cyclin. Recent studies have shown that CDK8, a subunit of the CDK/Cyclin module, is one of the key subunits of Mediator that mediates its pivotal roles in transcriptional regulation. In addition to CDK8, CDK19 was identified in human Mediator with a great deal of similarity to CDK8 but was conserved only in vertebrates. Previously, we reported that human CDK19 could form the Mediator complexes independent of CDK8. To further investigate the in vivo transcriptional activities of the complexes, we used a luciferase assay in combined with siRNA-mediated knockdown to show that CDK8 and CDK19 possess opposing functions in viral activator VP16-dependent transcriptional regulation. CDK8 supported transcriptional activation, whereas CDK19, however, counteracted it. In this study, we further characterized CDK19. We used microarrays to identify target genes for each CDK, and we selected six genes: two target genes of CDK8, two target genes of CDK19 and two genes that were targets for both. Surprisingly, it turned out that both CDKs bound to all six target genes, regardless of their effects in transcription upon binding, suggesting Mediator as a context-specific transcriptional regulator.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117896     DOI: 10.1111/j.1365-2443.2011.01565.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  23 in total

Review 1.  Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer.

Authors:  Eugenia V Broude; Balázs Győrffy; Alexander A Chumanevich; Mengqian Chen; Martina S J McDermott; Michael Shtutman; James F Catroppo; Igor B Roninson
Journal:  Curr Cancer Drug Targets       Date:  2015       Impact factor: 3.428

2.  A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.

Authors:  Timothy Cholko; Wei Chen; Zhiye Tang; Chia-En A Chang
Journal:  J Comput Aided Mol Des       Date:  2018-05-08       Impact factor: 3.686

3.  Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.

Authors:  Wei Chen; Xiaodong Ren; Chia-En A Chang
Journal:  ChemMedChem       Date:  2018-12-10       Impact factor: 3.466

4.  Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Authors:  Marco H Hofmann; Rajeswaran Mani; Harald Engelhardt; Maria A Impagnatiello; Sebastian Carotta; Marc Kerenyi; Seila Lorenzo-Herrero; Jark Böttcher; Dirk Scharn; Heribert Arnhof; Andreas Zoephel; Renate Schnitzer; Thomas Gerstberger; Michael P Sanderson; Girish Rajgolikar; Swagata Goswami; Sumithira Vasu; Peter Ettmayer; Segundo Gonzalez; Mark Pearson; Darryl B McConnell; Norbert Kraut; Natarajan Muthusamy; Jürgen Moll
Journal:  Mol Cancer Ther       Date:  2020-02-05       Impact factor: 6.261

5.  Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.

Authors:  Michael F T Koehler; Philippe Bergeron; Elizabeth M Blackwood; Krista Bowman; Kevin R Clark; Ron Firestein; James R Kiefer; Klaus Maskos; Mark L McCleland; Linda Orren; Laurent Salphati; Steve Schmidt; Elisabeth V Schneider; Jiansheng Wu; Maureen H Beresini
Journal:  ACS Med Chem Lett       Date:  2016-01-06       Impact factor: 4.345

6.  Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.

Authors:  Min Ju Park; Hailian Shen; Jason M Spaeth; Jaana H Tolvanen; Courtney Failor; Jennifer F Knudtson; Jessica McLaughlin; Sunil K Halder; Qiwei Yang; Serdar E Bulun; Ayman Al-Hendy; Robert S Schenken; Lauri A Aaltonen; Thomas G Boyer
Journal:  J Biol Chem       Date:  2018-02-13       Impact factor: 5.157

7.  Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.

Authors:  Taiki Tsutsui; Rikiya Fukasawa; Kaori Shinmyouzu; Reiko Nakagawa; Kazuyuki Tobe; Aki Tanaka; Yoshiaki Ohkuma
Journal:  J Biol Chem       Date:  2013-06-09       Impact factor: 5.157

Review 8.  Mediator kinase module and human tumorigenesis.

Authors:  Alison D Clark; Marieke Oldenbroek; Thomas G Boyer
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-07-16       Impact factor: 8.250

9.  Cyclin-dependent kinase 8 module expression profiling reveals requirement of mediator subunits 12 and 13 for transcription of Serpent-dependent innate immunity genes in Drosophila.

Authors:  Emilia Kuuluvainen; Heini Hakala; Essi Havula; Michelle Sahal Estimé; Mika Rämet; Ville Hietakangas; Tomi P Mäkelä
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

10.  Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities.

Authors:  Donald C Porter; Elena Farmaki; Serena Altilia; Gary P Schools; Deborah K West; Mengqian Chen; Bey-Dih Chang; Anatoliy T Puzyrev; Chang-uk Lim; Rebecca Rokow-Kittell; Lawrence T Friedhoff; Athanasios G Papavassiliou; Swathi Kalurupalle; Gregory Hurteau; Jun Shi; Phil S Baran; Balazs Gyorffy; Mark P Wentland; Eugenia V Broude; Hippokratis Kiaris; Igor B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.